跳至主要内容
临床试验/NCT03891602
NCT03891602已完成不适用

Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening

Hackensack Meridian Health1 个研究点 分布在 1 个国家目标入组 654 人开始时间: 2019年3月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
654
试验地点
1
主要终点
Key Components of Shared Decision Making Process That Predict Patient-perceived Lung Cancer Screening Decision Quality

研究概览

简要总结

The purpose of this study is to learn about discussion between clinicians and their patients related to lung screening. Survey answers will be collected from both clinicians and their patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • CLINICIANS:
  • Clinician (physician, nurse practitioner, or physician assistant)
  • Practicing in a KPWA primary care clinic
  • Having a patient panel with >/= 10 lung cancer screening eligible patients
  • PATIENTS (Quantitative Phase):
  • Age 55-80 years
  • >/= 30 pack-year tobacco smoking history
  • Current smoker or former smoker who has quit within the past 15 years
  • Documented SDM lung cancer screening discussion during a recent clinic visit

排除标准

  • Significant comorbidities (Charlson Comorbidity Index >/=3)
  • Lung cancer diagnosis

结局指标

主要结局

Key Components of Shared Decision Making Process That Predict Patient-perceived Lung Cancer Screening Decision Quality

时间窗: at baseline (study enrollment)

Decisional Quality was measured using the multidimensional Decisional Conflict Scale, a 16-item Likert-response scale that was modified by the investigators for the lung cancer screening context. The total score ranging from 0 to 64. This total score is commonly transformed into a standardized score that falls within a 0 to 100 range. Decisional quality measured on this numeric scale from which lower scores represent lower decisional conflict and, therefore, higher decisional quality. Scores below 25 have been associated with low decisional conflict.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lisa Carter-Bawa, PhD

Director | Cancer Prevention Precision Control Institute

Hackensack Meridian Health

研究点 (1)

Loading locations...

相似试验

DECIDE: Developing Tools for Lung Cancer Screening... | 临床试验